Targeting Aldose Reductase for the Treatment of Cancer

E-ISSN： 1873-5576|11|5|560-571

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.5, 2011-06, pp. : 560-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of aldose reductase inhibitors for the treatment of inflammatory disorders

By Chatzopoulou Maria Pegklidou Kyriaki Papastavrou Nikolaos Demopoulos Vassilis J

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1365-1380

Informa Healthcare

Access to resources Recommend Favorite

Targeting ribonucleotide reductase for cancer therapy

By Shao Jimin Liu Xiyong Zhu Lijun Yen Yun

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1423-1437

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Aldose Reductase in Diabetic Microvascular Complications

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose Reductase Inhibitors from the Nature

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1353-1374

Bentham Science Publishers

Access to resources Recommend Favorite